C
PFE icon

CEDRUS’s Pfizer PFE Stock Holding History

CEDRUS’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$435K Buy
15,048
+1,850
+14% +$54K 0.16% 105
2024
Q2 		$369K Buy
13,198
+821
+7% +$22.6K 0.18% 96
2024
Q1 		$343K Buy
12,377
+5,158
+71% +$143K 0.19% 104
2023
Q4 		$208K Sell
7,219
-1,483
-17% -$44.8K 0.13% 145
2023
Q3 		$289K Sell
8,702
-35
-0.4% -$1.24K 0.21% 112
2023
Q2 		$320K Sell
8,737
-452
-5% -$17.6K 0.23% 106
2023
Q1 		$375K Buy
9,189
+1,192
+15% +$51.5K 0.26% 84
2022
Q4 		$410K Buy
7,997
+1,158
+17% +$55.5K 0.33% 66
2022
Q3 		$299K Buy
6,839
+663
+11% +$32.2K 0.28% 72
2022
Q2 		$324K Buy
6,176
+432
+8% +$22K 0.32% 68
2022
Q1 		$297K Sell
5,744
-1,434
-20% -$74.4K 0.27% 95
2021
Q4 		$424K Buy
+7,178
New +$356K 0.41% 70

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

CEDRUS's PFE Position: Q3 2024 in Review

CEDRUS increased its Pfizer (PFE) stake by 14% in Q3 2024, buying an estimated $54K and bringing the position to 15,048 shares worth $435K. The position accounts for 0.16% of the portfolio, ranked #105.

CEDRUS first reported a position in PFE in Q4 2021 and has held it in 12 quarters since. 2,911 funds tracked by Wall St. Rank hold PFE as of Q3 2024.

  • CEDRUS held 15,048 shares of Pfizer worth $435K as of Q3 2024.
  • CEDRUS bought 1,850 Pfizer shares in Q3 2024, an estimated $54K.
  • Pfizer made up 0.16% of CEDRUS's portfolio in Q3 2024, its #105 holding.
  • CEDRUS first reported a position in Pfizer in Q4 2021 and has held it in 12 quarters since.
  • 2,911 funds tracked by Wall St. Rank held Pfizer as of Q3 2024.

Based on CEDRUS's 13F filing for Q3 2024, filed 18 Oct 2024.